Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-12 5:07 pm Unchanged | 2024-08-08 | 13D | Monte Rosa Therapeutics, Inc. GLUE | Versant Venture Capital VI, L.P. | 6,799,115 11.100% | 0 (Unchanged) | Filing History |
| 2024-05-13 8:40 pm Purchase | 2024-05-09 | 13D | Monte Rosa Therapeutics, Inc. GLUE | New Enterprise Associates 17, L.P. | 7,784,930 15.400% | 7,784,930 (New Position) | Filing History |
| 2024-04-10 12:58 pm Purchase | 2024-03-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | T. Rowe Price Associates, Inc. | 5,096,787 10.200% | 155,080 (+3.14%) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Baker Bros. Advisors LP | 4,916,095 9.800% | 4,916,095 (New Position) | Filing History |
| 2024-02-14 3:02 pm Sale | 2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Cormorant Asset Management, LP | 0 0.000% | -2,893,717 (Position Closed) | Filing History |
| 2024-02-14 11:22 am Sale | 2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | BlackRock Inc. BLK | 2,371,980 4.700% | -1,226,556 (-34.08%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | T. Rowe Price Associates, Inc. | 4,941,707 9.900% | 1,258,277 (+34.16%) | Filing History |
| 2024-02-14 09:14 am Purchase | 2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 4,535,000 9.100% | 210,000 (+4.86%) | Filing History |
| 2024-02-09 09:28 am Sale | 2024-02-08 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 5,537,239 11.056% | -680,219 (-10.94%) | Filing History |
| 2023-11-09 5:26 pm Unchanged | 2023-08-10 | 13D | Monte Rosa Therapeutics, Inc. GLUE | Versant Venture Capital VI, L.P. | 6,799,115 13.700% | 0 (Unchanged) | Filing History |
| 2023-02-14 3:11 pm Sale | 2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Cormorant Asset Management, LP | 2,893,717 5.980% | -108,483 (-3.61%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | T. Rowe Price Associates, Inc. | 3,683,430 7.600% | -1,175,197 (-24.19%) | Filing History |
| 2023-02-14 09:40 am Purchase | 2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 4,325,000 8.900% | 1,013,566 (+30.61%) | Filing History |
| 2023-02-09 12:01 pm Sale | 2023-02-09 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 6,217,458 12.846% | -758,429 (-10.87%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | BlackRock Inc. BLK | 3,598,536 7.400% | 2,006,738 (+126.07%) | Filing History |
| 2022-02-14 3:08 pm Sale | 2021-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Cormorant Asset Management, LP | 3,002,200 6.460% | -191,774 (-6.00%) | Filing History |
| 2022-02-11 10:06 am Purchase | 2021-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 3,311,434 7.100% | 3,311,434 (New Position) | Filing History |
| 2022-02-10 1:16 pm Purchase | 2022-01-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | T. Rowe Price Associates, Inc. | 4,858,627 10.400% | 711,708 (+17.16%) | Filing History |
| 2022-02-10 1:13 pm Purchase | 2021-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | T. Rowe Price Associates, Inc. | 4,146,919 8.900% | 4,146,919 (New Position) | Filing History |
| 2022-02-09 5:22 pm Sale | 2022-01-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | BlackRock Inc. BLK | 1,591,798 3.400% | -761,966 (-32.37%) | Filing History |